We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services
News

Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services

Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services
News

Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A global leader for genetic testing and next generation sequencing services, Ambry Genetics is a CLIA certified and CAP accredited Diagnostic and Genomic Services company providing solutions to both clinical and research clients.

“Ambry Genetics has dedicated its investments in technology for the benefit of the scientific and research community,” said Ardy Arianpour, Director of Business Development. “We are motivated to provide our Diagnostic, Genomic and Research customers with the best solutions for their projects, and the addition of RainDance’s RDT 1000 adds a sequence-enrichment offering while providing an option for customers that are in need of high-throughput targeted sequencing with a high level of coverage, completeness and speed.”

Researchers can utilize the RDT 1000 and Ambry Genetics Next Generation Services to either greatly reduce study time, or to improve study quality by running more samples in the same time within the same experimental budget.

“We’re pleased to partner with Ambry Genetics to provide our microdroplet PCR-based solution in conjunction with Ambry’s genetic testing and next generation sequencing services ” said Chris McNary, Chief Commercial Officer of, RainDance Technologies. “PCR is the gold standard for sequence enrichment and allows for high-resolution analysis of rare genetic variations, a focus area of Ambry Genetics’ customers”.   Ambry is currently offering RainDance’s sequence enrichment solution and may add two new applications, Methyl-Seq and Ultra-Deep Resequencing in the second half of 2010, further enhancing their customers’ ability to understand the origins and pathways of complex diseases."

Advertisement